Checkbiotech: 'Small green factories producing valuable natural products'
Posted by: DR. RAUPP ; madora
Date: April 01, 2005 07:28AM
www.czu.cz ; www.usab-tm.ro ; www.raupp.info
A new study showed that genetic engineering, combined with a solid knowledge
of plant metabolism, produced transgenic plants that more closely resembled
the original species than those produced through conventional breeding,
March 2005 by Christof Fellmann, Checkbiotech.
One major concern of consumers is that genetically engineered plants could
harm humans or the environment since they no longer correspond to the
natural product, from which they are derived. The first safety step with
transgenic plants is to see if they fit the standards of the principle of
substantial equivalence. In general, this principle requires that
genetically modified plants resemble their predecessors, or in some cases,
conventional plants. To assess this, a set of standard laboratory tests is
used. Further analysis includes toxicity and allergenicity tests.
Recently, Professor Soren Bak, from the Royal Veterinary and Agricultural
University, Copenhagen (Denmark) and his team demonstrated that metabolic
engineering offers the possibility to introduce new biosynthetic pathways
into plants, which then allow them to manufacture a desired product. Through
Dr. Bak's techniques, the product of interest will more strictly adhere to
the principle of substantial equivalence than organisms generated by
classical breeding techniques. Moreover, the scientist explain, in the
February edition of PNAS, that the introduction of a complex pathway into
the model plant Arabidopsis thaliana is possible with little to no
side-effects on the physiology of the plant.
For their study, Dr. Bak and his team chose to use the dhurrin pathway,
normally found in the crop Sorghum bicolor. Dhurrin is a cyanogenic
glucoside derived from the amino acid tyrosine. The reason for choosing this
pathway is that it, "Is unique in that only three cDNAs (copies of a gene)
need to be introduced in order to build the pathway. Biosynthetic pathways
for most other natural products such as alkaloids (plant synthesised organic
compounds containing nitrogen), for example, require 10 genes or more,
making the introduction of such pathways impractical," explained Dr. Bak.
Moreover, the dhurrin pathway is well studied so that genes involved are
known, and the molecular tools to handle the pathway are commonly used. For
example, it is well known that the end product, dhurrin, can be easily
extracted with alcohol in order to obtain a pure product.
As Dr. Bak explained, "Our plants are small green factories turning the
amino acid tyrosine into dhurrin. Maybe the use of GM crops in the fields at
the moment has a hard time especially in Europe, but growing small green
factories like our dhurrin plants for production of valuable natural
products under glass may be more understandable to the society."
When asked about what the interest in cyanogenic glucosides was, Dr Bak
responded, "Dhurrin, like other cyanogenic glucosides, are toxic in that
upon cellular disruption the glucosides are broken down and toxic HCN is
released." In other words, plants use cyanogenic glucosides as a weapon
against attacks by small animals and insects. When an insect bites a given
plant, and thereby disrupts cells, the cyanogenic glucosides are cleaved and
release cyanide (CN-).
Cyanides are strong toxins in that they block the respiratory pathway in
living organisms, by inhibiting the synthesis of ATP in targeted cells - the
cell's energy source. Cyanides is a so called inhibitors of the respiratory
pathway, because they block the electron flow by tightly binding to certain
cytochromes, thereby impeding the establishment of the proton motive force
needed for ATP production.
Dr. Bak mentioned, "We have shown using flee beetles in preference feeding
assays, that the presence of dhurrin repels the beetles. In that aspect,
introduction of dhurrin in transgenic crops like rapeseed could be
advantageous in that rapeseed fields are often attacked by flee beetles."
However, the main problem is not generating the plants, rather gaining their
acceptance. "Many of our agricultural crops like rice, wheat, and barley are
naturally producing cyanogenic glucosides, albeit at very low levels. The
cassava plant on the other hand accumulates very high levels in its starchy
tubers, and this is a health problem for millions of people in the tropics,"
said Dr. Bak.
If biosynthetic pathways can be built in such a way that toxic effects can
be avoided, for example by metabolic cross talk as successfully shown by Dr.
Bak and his team, and if the expression levels and place of expression are
controlled in such a way that the accumulation of the end product (dhurrin)
does not release toxic cyanides in unwanted places, transgenic plants may be
produced having broad scale beneficial effects.
Looking into the near future, Dr. Bak frames the benefits of his research
with the following perspective, "We have shown that natural products can be
altered in transgenic plants and that very high levels of metabolites can be
achieved without inadvertent effects. Our work thus paves the way for the
use of transgenic plants for the production of natural products."
Christof Fellmann is the Chief Scientific Writer for Checkbiotech, and a
student at the ESBS (www.dynamic-bio.com)
Posted to Phorum via PhorumMail